Call for proposals

18th Call for proposals 2019 - Innovative Medicines Initiative 2 Joint Undertaking - H2020-JTI-IMI2 H2020-JTI-IMI2-2019-18-two-stage Closed!

The Innovative Medicines Initiative 2 Joint Undertaking (IMI2 JU) has been created following the principles below:

Research related to the future of medicine should be undertaken in areas where societal, public health and biomedical industry competitiveness goals are aligned and require the pooling of resources and greater collaboration between the public and private sectors, with the involvement of Small- and Medium- sized Enterprises (SMEs).
The scope of the initiative should be expanded to all areas of life science research and innovation.
The areas should be of public health interest, as identified by the World Health Organisation (WHO) report on priority medicines for Europe and the World

This call covers the following topics

IMI2-2019-18-01: Central repository of digital pathology slides to support the development of artificial intelligence tools
IMI2-2019-18-02: Health Outcomes Observatories – empower patients with tools to measure their outcomes in a standardised manner creating transparency of health outcomes
IMI2-2019-18-03: Improving patient access, understanding and adherence to healthcare information: an integrated digital health information project
IMI2-2019-18-04: Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials
IMI2-2019-18-05: Accelerating research & innovation for advanced therapy medicinal products
IMI2-2019-18-06: Supporting the development of engineered T cells

The Community provisional funding available for the call for proposals is:

26 September 2019 - 6 months ago (Deadline for the presentation of proposals)

Opened to the following bodies or institutes with legal status established in the covered areas:

Bodies or institutes must have their registered legal seat in one of the countries taking part in the Programme which are:

Directorate-General for Research